Joseph ShavitJan 9, 2023Groundbreaking research identifies the cause of multiple sclerosisMultiple sclerosis, a progressive disease that affects 2.8 million people worldwide has no definitive cure and is likely caused by infection
Joseph ShavitDec 9, 2022Groundbreaking research finds the cause of multiple sclerosis and a possible cureMultiple sclerosis (MS), a progressive disease that affects 2.8 million people worldwide and for which there is no definitive cure.
Joseph ShavitNov 9, 2022Groundbreaking research identifies the cause of multiple sclerosisMultiple sclerosis (MS), a progressive disease that affects 2.8 million people worldwide and for which there is no definitive cure.
Joseph ShavitOct 17, 2022Researchers use digital cameras, machine learning to predict neurological diseaseIn order to streamline diagnosing patients with multiple sclerosis and Parkinson’s disease, researchers used cameras to capture gait data.
Joseph ShavitOct 9, 2022Harvard researchers identify the cause of multiple sclerosisMultiple sclerosis (MS), a progressive disease that affects 2.8 million people worldwide and for which there is no definitive cure.
Joseph ShavitMar 12, 2022Ketogenic diet significantly improves patients with Multiple SclerosisPatients with multiple sclerosis (MS) who adopted a high-fat, low-carbohydrate ketogenic diet saw significant improvements in their MS.
Joseph ShavitMar 2, 2022Engineer develops imitation red blood cells to deliver lifesaving drugsU of A researcher is building new drug delivery vehicles could improve efficacy and reduce negative side effects of lifesaving drugs.
Joseph ShavitJan 17, 2022It's not a COVID cure but study finds hydroxychloroquine may treat multiple sclerosisHydroxychloroquine, also known by the brand name Plaquenil, is a prescription drug that is used in the treatment of malaria and arthritis.